JPH1147580A - Production of liposome dispersion - Google Patents

Production of liposome dispersion

Info

Publication number
JPH1147580A
JPH1147580A JP20449197A JP20449197A JPH1147580A JP H1147580 A JPH1147580 A JP H1147580A JP 20449197 A JP20449197 A JP 20449197A JP 20449197 A JP20449197 A JP 20449197A JP H1147580 A JPH1147580 A JP H1147580A
Authority
JP
Japan
Prior art keywords
liposome
dispersion
particle size
liposome dispersion
jet stream
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP20449197A
Other languages
Japanese (ja)
Inventor
Satoyuki Kanemitsu
智行 金光
Tetsuji Inomata
哲二 猪股
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QP Corp
Original Assignee
QP Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QP Corp filed Critical QP Corp
Priority to JP20449197A priority Critical patent/JPH1147580A/en
Publication of JPH1147580A publication Critical patent/JPH1147580A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To produce a liposome dispersion excellent in long-term stability in an industrial scale in the liposome dispersion using saturated phospholipid as membrane lipid. SOLUTION: In a liposome dispersion using saturated phospholipid as membrane lipid, a rough dispersion of liposome is ejected as a single jet stream and the jet stream is directionally converted by a counterposed bottom surface to be allowed to flow backward along a side wall so as to surround the jet stream to apply finely pulverizing treatment to the liposome rough dispersion by the shearing force generated at the interface of the jet stream and the back flow to obtain liposome with an average particle size of 70 nm or less and the max. particle size of 300 nm or less.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、飽和のリン脂質を
リポソームの膜脂質として用いたリポソーム分散液にお
いて、安定性に優れたリポソーム分散液の製造方法に関
する。
TECHNICAL FIELD The present invention relates to a method for producing a liposome dispersion having excellent stability in a liposome dispersion using a saturated phospholipid as a membrane lipid of the liposome.

【0002】[0002]

【従来の技術】リポソームは、脂質よりなる二分子膜を
有し、その内部には水相を有した閉鎖小胞体である。リ
ポソームのこのような構造より、水溶性物質はリポソー
ムの内水相に、また、脂溶性物質は二分子膜間に保持す
ることが可能であるため、医薬分野では、種々の薬剤の
ドラッグデリバリーシステムの一種として研究されてい
る。また、化粧品分野では、脂質自体のエモリエント効
果及びリポソームが内水相を有することによる保水効果
を期待し化粧品への配合が試みられている。
2. Description of the Related Art A liposome is a closed vesicle having a bilayer made of lipid and having an aqueous phase therein. Due to such a structure of the liposome, the water-soluble substance can be retained in the internal aqueous phase of the liposome, and the fat-soluble substance can be retained between the bilayer membranes. It has been studied as a kind of. In the field of cosmetics, blending into cosmetics has been attempted with expectation of an emollient effect of lipids themselves and a water retention effect due to liposomes having an internal aqueous phase.

【0003】一方、リポソームの膜脂質としては、主に
リン脂質が用いられており、その中でもリポソームの膜
透過性及び酸化安定性の改善の観点から、飽和のリン脂
質が一般的に用いられている。また、リポソーム分散液
の工業的規模での生産は、一旦リポソームの粗分散液を
調製後、これを微粒子化装置、例えば、ゴーリンタイプ
等の高圧ホモゲナイザー、超音波照射機、ポリカーボネ
ート製メンブランフィルターでの高圧濾過等で処理する
方法で製造されている。
[0003] On the other hand, phospholipids are mainly used as membrane lipids of liposomes. Among them, saturated phospholipids are generally used from the viewpoint of improving membrane permeability and oxidative stability of liposomes. I have. Production of liposome dispersions on an industrial scale involves preparing a crude liposome dispersion, and then preparing the crude dispersion with a micronizing device, for example, a high-pressure homogenizer such as a Gorin type, an ultrasonic irradiator, or a polycarbonate membrane filter. It is manufactured by a method of processing by high pressure filtration or the like.

【0004】しかしながら、リポソームは、乳化物のよ
うに脂肪球の回りに乳化剤が固定された状態でなく、膜
内で脂質分子が横方向へ運動する側方拡散運動や二分子
膜間の脂質分子の移動であるフリップフロップ運動等リ
ポソーム内で膜脂質が様々な運動をしており、リポソー
ムの構造は熱力学的に安定なものとは言い難い状態であ
る。そのため、調製直後は安定なリポソーム分散液であ
っても、その後、リポソーム同士の凝集や融合が起こ
り、その結果、沈殿物の発生や不溶物の析出等外観変化
を来たし、リポソーム分散液の商品としての価値を損な
うこととなった。特に、飽和のリン脂質を膜脂質として
用いた場合は、分子自体がシリンダー型分子構造をして
いるため、構造的に閉鎖小胞体を保つことは、熱力学的
に安定とは言い難く、沈殿物等が発生し易い傾向にあっ
た。
However, a liposome is not a state in which an emulsifier is fixed around a fat globule like an emulsion, but a lateral diffusion movement in which a lipid molecule moves laterally in a membrane or a lipid molecule between bilayer membranes. The membrane lipids make various movements in the liposome, such as flip-flop movement, which is the movement of the liposome, and the structure of the liposome is hardly thermodynamically stable. For this reason, even if the liposome dispersion is stable immediately after preparation, liposomes will subsequently aggregate and fuse together, resulting in appearance changes such as the generation of precipitates and the precipitation of insolubles. The value of was lost. In particular, when a saturated phospholipid is used as a membrane lipid, since the molecule itself has a cylinder-type molecular structure, it is difficult to say that structurally maintaining closed vesicles is thermodynamically stable. Things tend to occur easily.

【0005】このようなリポソーム同士の凝集や融合を
防止する方法としては、リポソームの膜脂質の一部に荷
電物質、例えば、ホスファチジルセリン、ジセチルリン
酸、ホスファチジン酸、ホスファチジルイノシトール等
を用い表面電位を上げ、これによる静電気的反発力を利
用し凝集等を防止する方法が試みられているが、未だ十
分とは言い難い状況である。そこで、飽和のリン脂質を
膜脂質に用いた場合であっても長期安定性に優れたリポ
ソーム分散液が要望されている。
[0005] As a method for preventing such liposome aggregation and fusion, liposome membrane lipids are partially charged with a charged substance such as phosphatidylserine, dicetyl phosphate, phosphatidic acid, phosphatidylinositol or the like to increase the surface potential. Although a method of preventing agglomeration or the like by using an electrostatic repulsion force by this has been tried, it is still hard to say that it is sufficient. Therefore, there is a need for a liposome dispersion having excellent long-term stability even when a saturated phospholipid is used as a membrane lipid.

【0006】[0006]

【発明が解決しようとする課題】したがって、本発明の
目的は、飽和のリン脂質を膜脂質として用いたリポソー
ム分散液において、長期安定性に優れたリポソーム分散
液の工業規模での生産を可能ならしめるリポソーム分散
液の製造方法を提供することを目的とする。
Therefore, an object of the present invention is to provide a liposome dispersion using a saturated phospholipid as a membrane lipid so that a liposome dispersion having excellent long-term stability can be produced on an industrial scale. It is an object of the present invention to provide a method for producing a liposome dispersion liquid.

【0007】[0007]

【課題を解決するための手段】本発明者らは、前記の目
的を達成すべく鋭意研究を重ねた結果、本発明を完成す
るに至った。すなわち、本発明は、(1)飽和のリン脂
質をリポソームの膜脂質として用いたリポソーム分散液
において、該リポソームの粗分散液を単一のジェット流
として噴射させ、対向して配置された底面で該ジェット
流を方向転換させ、該ジェット流を包むように側壁に沿
い逆流させることによって、該ジェット流と逆流との界
面で発生する剪断力により該リポソーム粗分散液の微粒
子化処理を施し、平均粒子径が70nm以下であり、か
つ、最大粒子径が300nm以下のリポソームを得るリ
ポソーム分散液の製造方法、(2)リポソームの平均粒
子径が20〜70nmであり、かつ、最大粒子径が10
0〜300nmである(1)のリポソーム分散液の製造
方法、を提供するものである。
Means for Solving the Problems The present inventors have conducted intensive studies to achieve the above object, and as a result, completed the present invention. In other words, the present invention provides (1) a method for injecting a crude liposome dispersion as a single jet stream in a liposome dispersion using a saturated phospholipid as a membrane lipid of the liposome, The jet stream is changed in direction and is caused to flow back along the side wall so as to wrap the jet stream, whereby the coarse liposome dispersion is subjected to micronization treatment by a shear force generated at the interface between the jet stream and the back stream, and the average particle size is reduced. A method for producing a liposome dispersion having a diameter of 70 nm or less and a liposome having a maximum particle diameter of 300 nm or less, (2) a liposome having an average particle diameter of 20 to 70 nm and a maximum particle diameter of 10
(1) The method for producing a liposome dispersion of (1) having a thickness of 0 to 300 nm.

【0008】[0008]

【発明の実施の形態】以下本発明を詳細に説明する。
尚、本発明において「%」はすべて「重量%」であり、
粒子径はすべて「体積換算」による粒子径である。本発
明において「リン脂質」とは、分子内にリン酸基とアシ
ル基及び/又はアルキル基からなる疎水基を2個以上有
するものをいい、例えば、ホスファチジルコリン(P
C)、ホスファチジルエタノールアミン(PE)、ホス
ファチジルセリン(PS)、ホスファチジルイノシトー
ル(PI)、ホスハチジルグリセロール(PG)、ホス
ファチジン酸(PA)、スフィンゴミエリン(SP
M)、カルジオリピン又はこれらの誘導体の1種又は2
種以上の混合物等が挙げられる。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail.
In the present invention, “%” is all “% by weight”,
All particle diameters are particle diameters by “volume conversion”. In the present invention, the “phospholipid” refers to a substance having two or more hydrophobic groups comprising a phosphoric acid group and an acyl group and / or an alkyl group in a molecule, for example, phosphatidylcholine (P
C), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidylglycerol (PG), phosphatidic acid (PA), sphingomyelin (SP)
M), one or two of cardiolipin or derivatives thereof
And the like.

【0009】また、本発明において「飽和のリン脂質」
とは、リン脂質の疎水基であるアシル基及び/又はアル
キル基が飽和型であるものをいい、第十三改正日本薬局
方の油脂試験法の「ヨウ素価(IV)」に準じリン脂質
を分析したときIV=5以下のものも含まれる。このよ
うなリン脂質としては、例えば、ジパルミトイルホスフ
ァチジルコリン(DPPC)、卵黄リン脂質や植物由来
の例えば、大豆リン脂質等を水素添加により還元したも
の等が挙げられる。
In the present invention, "saturated phospholipid"
The term “phospholipid” refers to a phospholipid in which the acyl group and / or alkyl group, which is a hydrophobic group, is a saturated type. Phospholipids are prepared according to the “Iodine value (IV)” of the oil and fat test method of the thirteenth revised Japanese Pharmacopoeia. When analyzed, those having IV = 5 or less are also included. Examples of such phospholipids include dipalmitoyl phosphatidylcholine (DPPC), egg yolk phospholipids, and those derived from plant-derived soybean phospholipids by hydrogenation, and the like.

【0010】本発明において「リポソームの粗分散液」
とは、微粒子化処理を施す前のリポソーム分散液をい
い、その調製方法は特に限定されるものではないが、工
業的規模での生産としては、例えば、飽和のリン脂質を
水に分散後、相転移温度以上に加温する方法とか、相転
移温度以上に加温した水に飽和のリン脂質を分散させる
方法等が挙げられる。
In the present invention, "crude liposome dispersion"
The term refers to a liposome dispersion before subjecting to micronization treatment, and its preparation method is not particularly limited.However, as production on an industrial scale, for example, after dispersing a saturated phospholipid in water, Examples thereof include a method of heating to a temperature higher than the phase transition temperature and a method of dispersing a saturated phospholipid in water heated to a temperature of the phase transition temperature or higher.

【0011】また、本発明において「リポソームの粗分
散液を単一のジェット流として噴射させ、対向して配置
された底面で該ジェット流を方向転換させ、該ジェット
流を包むように側壁に沿い逆流させることによって、該
ジェット流と逆流との界面で発生する剪断力により該リ
ポソーム粗分散液の微粒子化処理を施し」とは、市販の
微粒子化装置であるB.E.E.International Ltd.製
のDeBEE2000又はこれに準ずる装置によりリポ
ソームの粗分散液を処理することをいう。以下、この微
粒子化原理を図1及び図2に従って説明する。リポソー
ムの粗分散液1をノズル2より単一のジェット流3とし
て噴射させ、対向して配置された底面4で該ジェット流
3を方向転換させ、該ジェット流3を包むように側壁5
に沿い逆流させることによって、該ジェット流3と逆流
6との界面7で発生する剪断力により該リポソーム粗分
散液の微粒子化処理を施す。
Further, in the present invention, it is preferable that "a crude liposome dispersion liquid is jetted as a single jet stream, the jet stream is turned at a bottom face which is arranged oppositely, and a backflow is applied along a side wall so as to wrap the jet stream. Thereby subjecting the crude liposome dispersion to micronization by the shearing force generated at the interface between the jet stream and the backflow. " E. FIG. E. FIG. This refers to treating a crude liposome dispersion with DeBEE2000 manufactured by International Ltd. or an apparatus equivalent thereto. Hereinafter, the principle of the formation of fine particles will be described with reference to FIGS. The crude liposome dispersion liquid 1 is jetted from a nozzle 2 as a single jet stream 3, the jet stream 3 is changed in direction at an opposed bottom surface 4, and a side wall 5 is wrapped around the jet stream 3.
, The shearing force generated at the interface 7 between the jet stream 3 and the back stream 6 causes the coarse dispersion of the liposome to be atomized.

【0012】本発明において「平均粒子径が70nm以
下であり、かつ、最大粒子径が300nm以下のリポソ
ーム」とは、本発明の製造方法により得られるリポソー
ム分散液のリポソームの粒子径を、市販の粒度分布分析
装置であるPacific Scientific製のNICOM Model37
0 又はこれに準ずる装置により測定したとき、平均粒子
径が70nm以下であり、かつ、最大粒子径が300n
m以下のものをいう。特に、平均粒子径が50nm以下
であり、かつ、最大粒子径が200nm以下のものは、
長期保存後も平均粒子径及び最大粒子径が調製直後と同
程度であり、外観も殆ど変化がなくより好ましい。一
方、平均粒子径が70nmより大きい、あるいは、最大
粒子径が300nmより大きいと調製直後は不溶物等は
観察されないが、保存後沈殿物等が発生し、リポソーム
分散液として好ましくない。また、他の微粒子化装置、
例えば、ゴーリンタイプの高圧ホモゲナイザー等で処理
して得られるリポソーム分散液のリポソームにおいて、
平均粒子径が70nm以下であり、かつ、最大粒子径が
300nm以下であったとしても、保存後沈殿物等が発
生し、リポソーム分散液として好ましくない。尚、平均
粒子径が20nmより小さく、かつ、最大粒子径が10
0nmより小さいリポソームは、本発明の製造方法を含
め実際には工業的規模で生産することは難しいので、本
発明の製造方法により得られるリポソームは、平均粒子
径が20〜70nmであり、かつ、最大粒子径が100
〜300nmである。
In the present invention, "a liposome having an average particle size of 70 nm or less and a maximum particle size of 300 nm or less" refers to a liposome particle size of a liposome dispersion obtained by the production method of the present invention, which is commercially available. NICOM Model37 manufactured by Pacific Scientific, a particle size distribution analyzer
0 or an equivalent particle size, the average particle diameter was 70 nm or less, and the maximum particle diameter was 300 n.
m or less. In particular, those having an average particle diameter of 50 nm or less, and a maximum particle diameter of 200 nm or less,
Even after long-term storage, the average particle size and the maximum particle size are almost the same as those immediately after preparation, and the appearance is hardly changed. On the other hand, if the average particle size is larger than 70 nm or the maximum particle size is larger than 300 nm, insolubles and the like are not observed immediately after preparation, but precipitates and the like are generated after storage, which is not preferable as a liposome dispersion. Also, other micronization devices,
For example, in a liposome of a liposome dispersion obtained by treatment with a Gaulin-type high-pressure homogenizer or the like,
Even if the average particle size is 70 nm or less and the maximum particle size is 300 nm or less, a precipitate or the like is generated after storage, which is not preferable as a liposome dispersion. Incidentally, the average particle diameter is smaller than 20 nm and the maximum particle diameter is 10 nm.
Since liposomes smaller than 0 nm are difficult to produce on an industrial scale, including the production method of the present invention, the liposomes obtained by the production method of the present invention have an average particle diameter of 20 to 70 nm, and Maximum particle size is 100
300300 nm.

【0013】本発明の製造方法により得られるリポソー
ム分散液には、特に制限はないが、医薬品や化粧料に用
いられる成分、例えば、シトシンアラビノシド、メトト
キセート、アドリアマイシン等の制癌剤、アムホテリシ
ンB、ゲンタマイシン、ピペラシリン等の抗生物質、グ
ルタチオン等の肝臓病薬、スーパーオキシドジスムター
ゼ、グルコアミラーゼ等の酵素、腫瘍壊死因子(TNF) 、
上皮成長因子(EGF) 、エリスロポエチン等の生理活性物
質、プロスタグランジン、ステロイド等のホルモン類、
ムラミルジペプタイド、リンホカイン、レンチナン等の
免疫賦活剤、DNA、RNAの核酸類、ビタミンA及び
その誘導体、ビタミンB類及びその誘導体、ビタミンC
及びその誘導体、ビタミンE及びその誘導体、ビタミン
D類、パントテン酸、ニコチン酸アミド等のビタミン
類、ヒアルロン酸、コンドロイチン硫酸、α−ヒドロキ
シ酸、ソルビトール、キシリトール、マルチトール等の
保湿剤、プロピレングリコール、1,3-ブチレングリコー
ル、グリセリン等の多価アルコール、月見草、アボガド
油、オリーブ油、ミンク油、脂肪酸類、スフィンゴ脂
質、リゾリン脂質、スクワレン、スクワラン、ステロー
ル類及びその誘導体等の油脂類、ポリビニルアルコー
ル、メチルセルロース等の増粘剤、エタノール等の有機
溶剤、その他有機酸、pH調整剤、防腐剤、消炎剤、キ
レート剤、天然エキス、香料等を配合することができ
る。
[0013] The liposome dispersion obtained by the production method of the present invention is not particularly limited, but components used for pharmaceuticals and cosmetics, for example, carcinostatic agents such as cytosine arabinoside, methotoxate and adriamycin, amphotericin B, gentamicin , Antibiotics such as piperacillin, liver diseases such as glutathione, superoxide dismutase, enzymes such as glucoamylase, tumor necrosis factor (TNF),
Epidermal growth factor (EGF), physiologically active substances such as erythropoietin, prostaglandins, hormones such as steroids,
Immunostimulants such as muramyl dipeptide, lymphokine and lentinan, nucleic acids of DNA and RNA, vitamin A and its derivatives, vitamin B and its derivatives, vitamin C
And its derivatives, vitamin E and its derivatives, vitamins D, pantothenic acid, vitamins such as nicotinamide, hyaluronic acid, chondroitin sulfate, α-hydroxy acid, sorbitol, xylitol, humectants such as maltitol, propylene glycol, Polyhydric alcohols such as 1,3-butylene glycol and glycerin, evening primrose, avocado oil, olive oil, mink oil, fatty acids, sphingolipids, lysophospholipids, squalene, squalane, fats and oils such as sterols and derivatives thereof, polyvinyl alcohol, Thickeners such as methylcellulose, organic solvents such as ethanol, other organic acids, pH adjusters, preservatives, anti-inflammatory agents, chelating agents, natural extracts, fragrances and the like can be added.

【0014】本発明の製造方法により得られるリポソー
ム分散液は、如何なる理由により保存安定性に優れてい
るかは定かではないが、本発明の微粒子化原理で平均粒
子径及び最大粒子径をコントロールすることにより、用
いた膜脂質よりできるリポソームの中でも熱力学的に安
定なリポソームが得られやすいことが、保存安定性に寄
与しているのではないかと推察される。
Although it is unclear for what reason the liposome dispersion obtained by the production method of the present invention has excellent storage stability, it is necessary to control the average particle diameter and the maximum particle diameter according to the micronization principle of the present invention. It is speculated that thermodynamically stable liposomes are easily obtained among liposomes made from the membrane lipid used, which may contribute to storage stability.

【0015】以下に、本発明の代表的な製造方法を説明
するが、特に、この製造方法に限定するものではない。リポソームの粗分散液の調製 飽和のリン脂質を相転移温度以上に加温した水に添加し
ホモミキサー等の攪拌機を用いて分散させるか、あるい
は、飽和のリン脂質を水に添加しホモミキサー等の攪拌
機を用い分散後、相転移温度以上に加温する。また、リ
ポソームの内水相や二分子膜内に医薬品や化粧料の成分
を内包させたリポソーム分散液を得たい場合、その成分
が水溶性成分のときは、水溶性成分を溶解させた水溶液
を上記の水に代えリポソームの粗分散液を調製するか、
あるいは、多価アルコールのように水溶性成分であって
も、飽和のリン脂質を溶解させるような成分は、飽和の
リン脂質をその成分で溶解させた溶液を水に添加し、上
記の方法によりリポソームの粗分散液を調製してもよ
い。さらに、内包させる成分が脂溶性成分のときは、そ
の成分を飽和のリン脂質と一緒に有機溶媒に溶解し、次
に溶媒を除去させたものを水に添加し、上記の方法によ
りリポソームの粗分散液を調製するか、あるいは、多価
アルコールのように飽和のリン脂質及び脂溶性成分を溶
解させる成分を有機溶媒として用いたときは、飽和のリ
ン脂質及び脂溶性成分をその成分で溶解させた溶液を水
に添加し、上記の方法によりリポソームの粗分散液を調
製してもよい。尚、飽和のリン脂質の相転移温度は、予
め示差走査熱量計(DSC)で測定しておく。
Hereinafter, a typical production method of the present invention will be described, but it is not particularly limited to this production method. Preparation of crude dispersion of liposome Add saturated phospholipid to water heated above the phase transition temperature and disperse using a stirrer such as a homomixer, or add saturated phospholipid to water and add a homomixer And then heated to a phase transition temperature or higher. In addition, when it is desired to obtain a liposome dispersion in which a pharmaceutical or cosmetic component is encapsulated in the internal aqueous phase or bilayer of the liposome, if the component is a water-soluble component, an aqueous solution in which the water-soluble component is dissolved is used. Prepare a crude dispersion of liposomes instead of water as described above,
Alternatively, even if a water-soluble component such as a polyhydric alcohol dissolves a saturated phospholipid, a solution in which the saturated phospholipid is dissolved with the component is added to water, and the above method is used. A crude liposome dispersion may be prepared. Furthermore, when the component to be encapsulated is a fat-soluble component, the component is dissolved in an organic solvent together with a saturated phospholipid, and then the solvent is removed and added to water. When a dispersion is prepared or a component that dissolves a saturated phospholipid and a fat-soluble component such as a polyhydric alcohol is used as an organic solvent, the saturated phospholipid and a fat-soluble component are dissolved in the component. The resulting solution may be added to water, and a crude liposome dispersion may be prepared by the above method. In addition, the phase transition temperature of the saturated phospholipid is measured in advance by a differential scanning calorimeter (DSC).

【0016】微粒子化処理によるリポソーム分散液の
調製 上記のリポソームの粗分散液を本発明の微粒子化原理を
利用した微粒子化装置、例えば、市販品であるDeBE
E2000を用い圧力25000psi以上で処理す
る。
[0016] The liposome dispersion liquid by the micronization treatment
Preparation A coarse dispersion of the above liposome is micronized using the micronization principle of the present invention, for example, a commercially available DeBE
Process at a pressure of 25000 psi or more using E2000.

【0017】次に、本発明を実施例・試験例に基づき、
さらに詳細に説明する。
Next, the present invention will be described based on Examples and Test Examples.
This will be described in more detail.

【実施例】実施例1 リポソームの粗分散液の調製 水素添加卵黄リン脂質(IV=4、脂質組成:PC=8
5%、PE=12%、SPM=1%、LPC=1%、そ
の他=1%)20gを約75℃に加温したプロピレング
リコール300gに溶解させる。一方、メチルパラベン
2gを溶解させた精製水1680gを約75℃に加温
し、ホモミキサー(特殊機化工業:T.K.ホモミクサー)
を用い10000rpmで攪拌させながら先の溶液を徐
々に添加し、さらに、10分間攪拌し、リポソームの粗
分散液を調製した。微粒子化処理によるリポソーム分散液の調製 上記のリポソームの粗分散液をDeBEE2000を用
い圧力30000psiで1回微粒子化処理を施し、リ
ポソーム分散液を得た。得られたリポソーム分散液は、
リポソームの平均粒子径が46nmであり、最大粒子径
が198nmであった。また、リポソーム分散液を50
mL(ミリリットル)容量のバイアル瓶に50mL充填
し密封後、40℃で6ヵ月保存したが、沈殿物や不溶物
は観察されなかった。
Example 1 Preparation of crude liposome dispersion Hydrogenated egg yolk phospholipid (IV = 4, lipid composition: PC = 8)
(5%, PE = 12%, SPM = 1%, LPC = 1%, other = 1%) 20 g is dissolved in 300 g of propylene glycol heated to about 75 ° C. On the other hand, 1680 g of purified water in which 2 g of methylparaben was dissolved was heated to about 75 ° C., and a homomixer (special machine chemical industry: TK homomixer) was used.
While stirring at 10,000 rpm, the above solution was gradually added, and the mixture was further stirred for 10 minutes to prepare a crude dispersion of liposomes. Preparation of liposome dispersion by micronization treatment The crude liposome dispersion was subjected to micronization treatment once using DeBEE2000 at a pressure of 30,000 psi to obtain a liposome dispersion. The resulting liposome dispersion is
The average particle size of the liposome was 46 nm, and the maximum particle size was 198 nm. In addition, 50 liposome dispersions were added.
After filling 50 mL into a vial bottle having a capacity of mL (milliliter) and sealing, it was stored at 40 ° C. for 6 months, but no precipitate or insoluble matter was observed.

【0018】実施例1 リポソームの粗分散液の調製 メチルパラベン2gを溶解させた精製水1960gを約
75℃に加温し、ホモミキサー(特殊機化工業:T.K.ホ
モミクサー)を用い10000rpmで攪拌させながら
水素添加卵黄リン脂質(IV=1、脂質組成:PC=8
8%、PE=10%、SPM=0.5%、LPC=0.
5%、その他=1%)40gを徐々に添加し、さらに、
10分間攪拌し、リポソームの粗分散液を調製した。微粒子化処理によるリポソーム分散液の調製 上記のリポソームの粗分散液をDeBEE2000を用
い圧力45000psiで4回微粒子化処理を施し、リ
ポソーム分散液を得た。得られたリポソーム分散液は、
リポソームの平均粒子径が23nmであり、最大粒子径
が104nmであった。また、リポソーム分散液を50
mL(ミリリットル)容量のバイアル瓶に50mL充填
し密封後、40℃で6ヵ月保存したが、沈殿物や不溶物
は観察されなかった。
Example 1 Preparation of crude liposome dispersion 1960 g of purified water in which 2 g of methylparaben was dissolved was heated to about 75 ° C., and hydrogen was stirred at 10,000 rpm using a homomixer (Toki Hikami Kogyo: TK homomixer). Added egg yolk phospholipids (IV = 1, lipid composition: PC = 8
8%, PE = 10%, SPM = 0.5%, LPC = 0.
5%, other = 1%) 40 g gradually added,
The mixture was stirred for 10 minutes to prepare a crude liposome dispersion. Preparation of Liposomal Dispersion by Micronization Treatment The above crude liposome dispersion was micronized four times at 45,000 psi using DeBEE2000 to obtain a liposome dispersion. The resulting liposome dispersion is
The average particle size of the liposome was 23 nm, and the maximum particle size was 104 nm. In addition, 50 liposome dispersions were added.
After filling 50 mL into a vial bottle having a capacity of mL (milliliter) and sealing, it was stored at 40 ° C. for 6 months, but no precipitate or insoluble matter was observed.

【0019】[0019]

【試験例】試験例1 試験方法 実施例1のリポソーム粗分散液を用い、その後の微粒子
化処理において、処理圧力、処理回数及び微粒子化装置
を代え表1の保存前に示すリポソーム分散液を調製し
た。このリポソーム分散液を50mL(ミリリットル)
容量のバイアル瓶に50mL充填し密封後、40℃で6
ヵ月保存し、保存前後のリポソームの平均粒子径及び最
大粒子径と目視により分散液の状態を比較し、各分散液
の保存安定性を評価した。尚、粒子径の測定は下記の条
件で行った。 粒度分布分析装置:NICOMP Model370(Pacific Sc
ientific製) 測定モード :Solid Particles (体積換算) 積算時間 :10分以上 Residual :2.0以下
[Test example] Test example 1 Test method In the subsequent micronization treatment, the liposome dispersion shown in Table 1 before storage was prepared by using the crude liposome dispersion of Example 1 and changing the processing pressure, the number of treatments and the micronization apparatus. did. 50 mL (milliliter) of this liposome dispersion
After filling 50 mL into a vial with a capacity and sealing,
The dispersion was stored for months, and the state of the dispersion was visually compared with the average particle diameter and the maximum particle diameter of the liposome before and after the storage, and the storage stability of each dispersion was evaluated. The particle size was measured under the following conditions. Particle size distribution analyzer: NICOMP Model370 (Pacific Sc
Measurement mode: Solid Particles (converted to volume) Integration time: 10 minutes or more Residual: 2.0 or less

【0020】[0020]

【表1】 [Table 1]

【0021】試験結果を表1に示す。本発明品No.1
〜4及び対照品No.1〜2より、本発明の微粒子化原
理で調製したリポソーム分散液でも、平均粒子径が70
nmより大きい場合、あるいは、最大粒子径が300n
mより大きい場合は、保存後に沈殿物、あるいは、不溶
物が発生し好ましくないのに対し、平均粒子径が70n
m以下であり、かつ、最大粒子径が300nm以下のも
のは、保存後も沈殿物等の発生がなく保存安定性に優れ
ていることが理解できる。特に、本発明品No.1〜2
の平均粒子径が50nm以下であり、かつ、最大粒子径
が200nm以下のものは、保存前後で平均粒子径、最
大粒子径共に殆ど変化がなく、また、分散液の状態も保
存前の状態を保持されており保存安定性により優れてい
ることが理解される。
Table 1 shows the test results. Product No. of the present invention 1
-4 and the control product No. 1 and 2, the average particle diameter of the liposome dispersion prepared by the micronization principle of the present invention was 70%.
nm or the maximum particle size is 300n
When the average particle diameter is larger than 70n, a precipitate or an insoluble matter is generated after storage, which is not preferable.
m and a maximum particle diameter of 300 nm or less can be understood to be excellent in storage stability without generation of precipitates and the like even after storage. In particular, the product No. 1-2
Is less than 50 nm, and those having a maximum particle size of 200 nm or less have almost no change in both the average particle size and the maximum particle size before and after storage, and the state of the dispersion is also the state before storage. It is understood that they are retained and are more excellent in storage stability.

【0022】また、本発明品No.1〜4及び対照品N
o.3〜4より、たとえ平均粒子径が70nm以下、か
つ、最大粒子径が300nm以下であっても、本発明の
微粒子化原理で調製しないと、保存後に沈殿物、あるい
は、不溶物が発生し好ましくないことが理解される。
Also, the product No. of the present invention. 1-4 and control product N
o. From 3 to 4, even if the average particle size is 70 nm or less, and even if the maximum particle size is 300 nm or less, unless prepared according to the micronization principle of the present invention, a precipitate or an insoluble matter is preferably generated after storage. It is understood that there is no.

【0023】[0023]

【発明の効果】以上述べたように、従来の製造方法には
みられなかった長期間安定性に優れてたリポソーム分散
液が得られることより、医薬・化粧品分野は勿論のこと
他の分野においてもさらに用途拡大が期待される。
As described above, a liposome dispersion having excellent long-term stability, which has not been observed in the conventional production method, can be obtained. Therefore, the liposome dispersion can be obtained not only in the fields of medicine and cosmetics but also in other fields. Is also expected to expand applications.

【0024】[0024]

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の微粒子化原理を説明するための側断面
図である。
FIG. 1 is a side sectional view for explaining the principle of forming fine particles of the present invention.

【図2】図1のA−A矢視の横断面図である。FIG. 2 is a cross-sectional view taken along the line AA of FIG.

【符号の説明】[Explanation of symbols]

1 リポソームの粗分散液 2 ノズル 3 ジェット流 4 底面 5 側壁 6 逆流 7 界面 DESCRIPTION OF SYMBOLS 1 Crude liposome dispersion 2 Nozzle 3 Jet flow 4 Bottom surface 5 Side wall 6 Reverse flow 7 Interface

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 飽和のリン脂質をリポソームの膜脂質と
して用いたリポソーム分散液において、該リポソームの
粗分散液を単一のジェット流として噴射させ、対向して
配置された底面で該ジェット流を方向転換させ、該ジェ
ット流を包むように側壁に沿い逆流させることによっ
て、該ジェット流と逆流との界面で発生する剪断力によ
り該リポソーム粗分散液の微粒子化処理を施し、平均粒
子径が70nm以下であり、かつ、最大粒子径が300
nm以下のリポソームを得ることを特徴とするリポソー
ム分散液の製造方法。
In a liposome dispersion using a saturated phospholipid as a membrane lipid of a liposome, a crude dispersion of the liposome is jetted as a single jet stream, and the jet stream is jetted at a bottom face arranged opposite to the liposome. By changing the direction and flowing back along the side wall so as to envelop the jet flow, the coarse liposome dispersion is subjected to micronization treatment by the shear force generated at the interface between the jet flow and the back flow, and the average particle diameter is 70 nm or less. And the maximum particle size is 300
A method for producing a liposome dispersion, characterized in that a liposome having a diameter of at most nm is obtained.
【請求項2】 リポソームの平均粒子径が20〜70n
mであり、かつ、最大粒子径が100〜300nmであ
る、請求項1記載のリポソーム分散液の製造方法。
2. The liposome has an average particle size of 20 to 70 n.
2. The method for producing a liposome dispersion according to claim 1, wherein m and the maximum particle diameter are 100 to 300 nm.
JP20449197A 1997-07-30 1997-07-30 Production of liposome dispersion Pending JPH1147580A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20449197A JPH1147580A (en) 1997-07-30 1997-07-30 Production of liposome dispersion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20449197A JPH1147580A (en) 1997-07-30 1997-07-30 Production of liposome dispersion

Publications (1)

Publication Number Publication Date
JPH1147580A true JPH1147580A (en) 1999-02-23

Family

ID=16491417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20449197A Pending JPH1147580A (en) 1997-07-30 1997-07-30 Production of liposome dispersion

Country Status (1)

Country Link
JP (1) JPH1147580A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001506541A (en) * 1997-09-09 2001-05-22 セレクト リリース リミテッド カンパニー Coated particles and their production and use
JP2001278811A (en) * 2000-03-29 2001-10-10 Nonogawa Shoji Kk Skin care preparation
JP2002193790A (en) * 2000-12-27 2002-07-10 Lion Corp Oil-in-water type emulsion containing scarcely water- soluble drug and method of producing the same
JP2002226402A (en) * 2001-02-02 2002-08-14 Nonogawa Shoji Kk Skin care preparation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001506541A (en) * 1997-09-09 2001-05-22 セレクト リリース リミテッド カンパニー Coated particles and their production and use
JP2001278811A (en) * 2000-03-29 2001-10-10 Nonogawa Shoji Kk Skin care preparation
JP2002193790A (en) * 2000-12-27 2002-07-10 Lion Corp Oil-in-water type emulsion containing scarcely water- soluble drug and method of producing the same
JP2002226402A (en) * 2001-02-02 2002-08-14 Nonogawa Shoji Kk Skin care preparation
JP4675483B2 (en) * 2001-02-02 2011-04-20 日本メナード化粧品株式会社 Skin preparation

Similar Documents

Publication Publication Date Title
EP0130577B2 (en) Method for producing liposomes
JP4203394B2 (en) Micronized liposomes containing a high concentration of triterpenoid and method for producing the same
US4830857A (en) Cosmetic and pharmaceutical compositions containing niosomes and a water-soluble polyamide, and a process for preparing these compositions
US5665379A (en) Lipid particle forming matrix, preparation and use thereof
TWI241915B (en) A method of preparing a pharmaceutical end formulation using a nanodispersion
JP4758915B2 (en) Multilamellar liposome and production method thereof
KR100654841B1 (en) Lipid solution composition and method for preparing nano particle cosmetics having analogous structure and composition of human skin and promoting the transepidermal absorption of physiologically active substances using the same
KR100921959B1 (en) Multi-Emulsified Vesicles Comprising a Multi Lamellar Liposome and Phospholipid Monolayer Nanoliposomes
JPH0549334B2 (en)
EP0514506B1 (en) Lipid formulation system
Mishra et al. Nanoemulsion: a novel drug delivery tool
JP4228230B2 (en) Method for producing liposome suspension and use using liposome
KR20070113711A (en) Anti-wrinkle cosmetic composition encapsulating idebenone with nano sizes and its manufacturing method
KR20060061879A (en) Cosmetic composition comprising nano size liposome and oil in water type emulsion and manufacturing method thereof
HUT73531A (en) Ketoprofene liposomes
WO2009142018A1 (en) Method for producing vesicle, vesicle obtained by the production method, and w/o/w emulsion for producing vesicle
JP2005179313A (en) Method for producing base agent for skin cosmetic, and skin cosmetic
JPH1147580A (en) Production of liposome dispersion
KR20200070091A (en) Nano-lipid carrier for encapsulation of physiologically active substance and preparation method thereof
JP3783385B2 (en) Method for producing liposome dispersion and cosmetic using the same
KR20190022247A (en) Method for the Preparation of Cosmetic Composition Comprising Mixed Ceramides and Cosmetic Composition Prepared by the Same
JPH06239734A (en) Preparation of liposome and loposome formulation
KR20190134582A (en) Method for the Preparation of Cosmetic Composition Comprising Mixed Ceramides and Cosmetic Composition Prepared by the Same
JPH0437731B2 (en)
JP2001522795A (en) Preparation of liposomes

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040517

A131 Notification of reasons for refusal

Effective date: 20080129

Free format text: JAPANESE INTERMEDIATE CODE: A131

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080324

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090623